(NASDAQ: HYPR) Hyperfine's forecast annual revenue growth rate of 27.35% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.85%, and it is also forecast to beat the US market's average forecast revenue growth rate of 26.17%.
Hyperfine's revenue in 2025 is $10,797,000.On average, 4 Wall Street analysts forecast HYPR's revenue for 2025 to be $1,142,567,755, with the lowest HYPR revenue forecast at $1,093,533,210, and the highest HYPR revenue forecast at $1,180,758,121. On average, 3 Wall Street analysts forecast HYPR's revenue for 2026 to be $1,554,960,848, with the lowest HYPR revenue forecast at $1,493,981,991, and the highest HYPR revenue forecast at $1,600,694,990.
In 2027, HYPR is forecast to generate $1,707,250,828 in revenue, with the lowest revenue forecast at $1,640,299,815 and the highest revenue forecast at $1,757,464,087.